VeriSign Faces Monopoly Lawsuit With CEO Unloading Stock
VeriSign faces a monopoly antitrust lawsuit challenging its exclusive .com and .net registry, with CEO James Bidzos selling shares across six consecutive Mondays. The case threatens to undermine the p
VeriSign Faces Monopoly Lawsuit With CEO Unloading Stock
NEW YORK, September 13 —
VeriSign, Inc. (VRSN) is the sole-authorized registry for .com and .net, a structural advantage that built its business and that a reported antitrust lawsuit now treats as the offense. Analysts say the filing "could change the bull case," and shares fell 3.4% in the session following the news.
- CEO Bidzos sold 3,300 shares on each of six consecutive Mondays from August 4 through September 8 under a preset 10b5-1 plan
- Net insider activity over 90 days: $0.01M purchased against $6.30M sold, driven almost entirely by the CEO's disposal program
- Trailing free cash flow of $833M on $1.71B revenue, with 88.5% gross margins requiring essentially no physical inputs
The Economics That Are Now on Trial
VeriSign operates the authoritative resolution infrastructure for .com and .net, the internet's two largest generic domains, with no competitive bid process that could displace it. That franchise is why 926 employees generate $1.71B in trailing revenue at 6.0% growth, why gross margins sit at 88.5%, and why annual free cash flow reaches $833M with essentially no physical inputs. The lawsuit reportedly argues that the exclusivity itself is the antitrust violation, putting the pricing architecture that underpins every valuation model directly in the dock. A DCF calculator applied to those cash flows shows how sensitive the valuation is to any compression in registry pricing power.
Six Mondays in a Row
Per Form 4 filings, CEO D. James Bidzos sold exactly 3,300 shares on each of six consecutive Mondays since August 4, with his September 8 block executed across seven tranches at prices from $279.66 to $289.16. General Counsel Thomas Indelicarto sold 500 shares on four dates in the same window, also under a preset 10b5-1 plan per filings. Against this, Director Courtney Armstrong made the period's only purchases on August 27: roughly 19.3 shares totaling approximately $5,671. Net 90-day insider activity stands at $0.01M purchased against $6.30M sold.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| VRSN | $26.5B | 26.6x | +1.6% |
| CHKP | $13.4B | 11.7x | -33.5% |
| NTAP | $39.1B | 18.0x | +60.5% |
| AKAM | $15.3B | 14.9x | +39.7% |
| VRTS | $976M | 6.0x | -24.3% |
| INTU | $85.9B | 11.8x | -50.6% |
What the Next Checkpoint Reveals
The antitrust case will likely turn on whether VeriSign's ICANN-granted exclusivity constitutes an illegitimate barrier to competition under antitrust law. Separately, a 424B5 prospectus supplement filed June 18 and dual 8-Ks filed June 26 signal capital markets activity in the weeks before the lawsuit drew public attention. Quarterly earnings are the next formal test: any change to guidance on .com renewal pricing is the signal that either holds or breaks the existing premium. Run the free VeriSign, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
What makes VeriSign's .com monopoly so valuable?
VeriSign is the sole-authorized registry for .com and .net, the internet's two largest generic domains, with no competitive bid process that could displace it. This exclusivity generates $1.71 billion in trailing revenue with 88.5% gross margins and $833 million in annual free cash flow from just 926 employees.
Why does VeriSign face an antitrust lawsuit?
The lawsuit reportedly argues that VeriSign's exclusive ICANN-granted registry status constitutes an illegitimate barrier to competition under antitrust law. Analysts say the filing "could change the bull case," as it directly threatens the pricing power on which the company's premium valuation depends.
Why is CEO James Bidzos selling stock?
CEO Bidzos sold exactly 3,300 shares on each of six consecutive Mondays from August 4 through September 8 under a preset 10b5-1 plan. Net 90-day insider activity stands at $0.01 million purchased against $6.30 million sold, driven almost entirely by the CEO's disposal program.
What's the next checkpoint in this case?
Quarterly earnings will be the next formal checkpoint. Any change to guidance on .com renewal pricing would be the specific signal that either defends or breaks the existing premium valuation.
A monopoly lawsuit targeting VeriSign's exclusive .com and .net registry franchise has analysts asking whether the stock's premium is still justified — even as CEO D. James Bidzos has sold exactly 3,300 shares on each of six consecutive Mondays under a preset trading plan.